Nan Fung Group Holdings »

Tourmaline Bio shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.9M 147k 12.86
2024-03-31 $481k 21k 22.90

More positions owned by Nan Fung Group Holdings

Illumina (ILMN)
Harmony Biosciences Hldgs In (HRMY)
Merus N V (MRUS)
Geron Corporation (GERN)
Oculis Holding Ordinary Shares (OCS)
Incyte Corporation (INCY)
Exscientia Ads (EXAI)
Xenon Pharmaceuticals (XENE)
Longboard Pharmaceuticals In (LBPH)
Mirum Pharmaceuticals (MIRM)
D Fluidigm Corp Del (LAB)
Beigene Sponsored Adr (BGNE)
Kalvista Pharmaceuticals (KALV)
Rhythm Pharmaceuticals (RYTM)
Tourmaline Bio (TRML)

View all positions for Nan Fung Group Holdings

Top funds holding Tourmaline Bio

RA Capital Management
venBio Select Advisor
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Jennison Associates
Vanguard Group
Qiming U.S. Ventures Management
Rtw Investments
QVT Financial
Nantahala Capital Management
Vivo Capital
Citadel Advisors
Geode Capital Management
State Street Corporation

View all funds holding Tourmaline Bio